Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab in Active Rheumatoid Arthritis
NCT00727987Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2008
- Primary completion
- Dec 2011
- Countries
- 1
01
Overview
A Phase 3 trial of golimumab in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Started May 2008; status: completed.
02
Drugs
golimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00727987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00727987.